In addition, previous studies revealed that targeting the CB1R is associated with adverse effects including anxiety, depression and even suicidal ideation (69, 70), and hence the search for a new therapeutic targets with minimal adverse effect is gaining special attention. The gene discussed is CNR1; the disease is depressive symptom measurement.